| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/10/2000 | CA2339096A1 Modulation of apoptosis |
| 02/10/2000 | CA2338912A1 Medicine nitrate salts |
| 02/10/2000 | CA2338764A1 Substituted anilide compounds and methods |
| 02/10/2000 | CA2338697A1 Compounds and methods |
| 02/10/2000 | CA2338396A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | CA2338330A1 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 02/10/2000 | CA2338275A1 Integrin receptor antagonists |
| 02/10/2000 | CA2338019A1 Prostate derived ets factor |
| 02/10/2000 | CA2336543A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | CA2336536A1 Growth differentiation factor-11 |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/09/2000 | EP0978517A2 Triazolopurines, process for their preparation and their use as medicaments |
| 02/09/2000 | EP0978277A1 Antirheumatic agents |
| 02/09/2000 | EP0977892A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes |
| 02/09/2000 | EP0977850A1 Edg-1-like receptor |
| 02/09/2000 | EP0977753A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension |
| 02/09/2000 | EP0977749A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0977743A1 Protease inhibitors |
| 02/09/2000 | EP0977741A1 Substituted phenyl derivatives, their preparation and use |
| 02/09/2000 | EP0977735A1 Vitronectin receptor antagonists |
| 02/09/2000 | EP0977734A2 Arylsecocholadiene derivatives |
| 02/09/2000 | EP0977733A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/09/2000 | EP0977581A1 Histone containing composition to treat rheumatoid arthritis |
| 02/09/2000 | EP0977576A1 Osteoblast-promoting pharmaceutical composition comprising a carnitine compound and dhea or dhea-s |
| 02/09/2000 | EP0977571A1 Piperazine derivatives for treating bone deficit conditions |
| 02/09/2000 | CN1244128A Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 02/09/2000 | CN1244124A Amorphous benzothiophenes, methods of preparation, and methods of use |
| 02/09/2000 | CN1244112A Material intended to remineralise organomineral tissues |
| 02/09/2000 | CN1243734A Medicine for treating rheumatic diseases |
| 02/09/2000 | CN1243722A Medicine for treating bone fracture and its preparing process |
| 02/09/2000 | CN1243703A Snake wine |
| 02/08/2000 | US6022894 Method of using calcilytic compounds |
| 02/08/2000 | US6022887 Compositions and methods for stimulating bone growth |
| 02/08/2000 | US6022884 Substituted pyridine compounds and methods of use |
| 02/08/2000 | US6022873 Metalloproteinase inhibitors |
| 02/08/2000 | US6022540 Ligands that modulate differentiation of mesenchymal stem cells |
| 02/08/2000 | CA2014467C 3-substituted-2-oxindole derivatives |
| 02/06/2000 | CA2279747A1 Estrogen agonists/antagonists |
| 02/03/2000 | WO2000005388A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005361A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005254A2 Novel peptides for use in immunotherapy of autoimmune diseases |
| 02/03/2000 | WO2000005249A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | WO2000005245A2 Inhibitors of urokinase and blood vessel formation |
| 02/03/2000 | WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 02/03/2000 | WO2000005232A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 02/03/2000 | WO2000005224A2 Heterocyclic derivatives and their use as integrin inhibitor |
| 02/03/2000 | WO2000005223A2 Heterocyclic derivatives and their use as integrin inhibitors |
| 02/03/2000 | WO2000005216A1 Il-8 receptor antagonists |
| 02/03/2000 | WO2000005207A1 Substituted phenylamidines with antithrombotic action |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004868A2 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | WO1999059620A9 Angiostatin receptor |
| 02/03/2000 | WO1998055483A9 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 02/03/2000 | DE19834713A1 Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New phenylethylamine derivatives, processes for their preparation and their use as medicaments |
| 02/03/2000 | DE19831382A1 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung Human m¶3¶G-cap-specific nuclear import receptor protein with a new domain tree, its preparation and use |
| 02/03/2000 | CA2338741A1 Il-8 receptor antagonists |
| 02/03/2000 | CA2338524A1 Inhibitors of urokinase and blood vessel formation |
| 02/03/2000 | CA2337756A1 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | CA2337413A1 Substituted phenylamidines,pharmaceutical compositions containing these compounds and processes for preparing them |
| 02/03/2000 | CA2337247A1 Isquinolines as urokinase inhibitors |
| 02/03/2000 | CA2336238A1 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | CA2335646A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | CA2334947A1 Novel peptides for use in immunotherapy of autoimmune diseases |
| 02/02/2000 | EP0975754A1 Osteoprotegerin binding proteins and receptors |
| 02/02/2000 | EP0975752A1 Human cerberus protein |
| 02/02/2000 | EP0975743A1 Inhibitors for urokinase receptor |
| 02/02/2000 | EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA |
| 02/02/2000 | EP0975636A1 Novel compounds |
| 02/02/2000 | EP0975612A1 Protease inhibitors |
| 02/02/2000 | EP0975589A2 Dialkyl ureas as calcitonin mimetics |
| 02/02/2000 | EP0975350A1 Use of an extract of alchemilli vulgaris |
| 02/02/2000 | CN1243507A Bis-sulfonomides hydroxamic acids as MMP inhibitors |
| 02/02/2000 | CN1243005A Bone-setting and muscle-jointing-up medicine and preparation method thereof |
| 02/01/2000 | US6020366 Butyric acid matrix metalloproteinase inhibitors |
| 02/01/2000 | US6020363 Isocoumarin derivatives and use thereof in drugs |
| 02/01/2000 | US6020358 Substituted phenethylsulfones and method of reducing TNFα levels |
| 02/01/2000 | US6020326 Method for inhibition of bone growth by anionic polymers |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 02/01/2000 | US6020179 Nucleic acids encoding human tyrosine phosphatases |
| 01/27/2000 | WO2000004183A1 Bone morphogenic protein |
| 01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | WO2000004030A1 Phosphinous and phosphonic acid derivatives used as medicaments |
| 01/27/2000 | WO2000003992A1 Quinoline derivatives |
| 01/27/2000 | WO2000003991A1 Quinoline derivatives |
| 01/27/2000 | WO2000003979A1 Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments |
| 01/27/2000 | WO2000003977A1 Alpha-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and their use for treating inflammation |
| 01/27/2000 | WO2000003973A1 Diacylhydrazine derivatives as integrin inhibitors |
| 01/27/2000 | WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof |
| 01/27/2000 | DE19833105A1 New N-amidinophenyl-1-carboxymethyl-4-piperidinepropanamide derivatives useful as antithrombotic, antiaggregatory, antitumor, antimetastatic, antiinflammatory and anti-osteoporosis agents |
| 01/27/2000 | CA2337850A1 Alpha-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and their use for treating inflammation |
| 01/27/2000 | CA2337305A1 Diacylhydrazine derivatives |
| 01/27/2000 | CA2334075A1 Bone morphogenic protein |
| 01/27/2000 | CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/26/2000 | EP0974058A2 20 human secreted proteins |
| 01/26/2000 | EP0973890A2 Secreted proteins and polynucleotides encoding them |
| 01/26/2000 | EP0973793A1 Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same |